N-Power Medicine, backed by Merck GHI, announced the acquisition of Syapse Holdings. Samsung Biologics and LigaChem extended their ADC services deal. Publicis Worldwide merged with Leo Burnett to form ...

Bank of America Securities analyst Tim Anderson maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today. The company’s ...

Kenvue isn't growing as quickly as Eli Lilly or Zoetis, but it offers investors a strong starting point for dividend income.

Eli Lilly has claimed FDA approval for its IL-23 inhibitor Omvoh as a treatment for moderately to severely active Crohn's ...

Omvoh’s label expansion is important progress for Eli Lilly as it works to diversify its portfolio beyond obesity, according ...

Here's a quick recap of what I've seen in the biotech and pharma space so far: Johnson & Johnson stole the show when it ... especially under a likely deal-friendly Trump administration. Eli Lilly said ...

The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...

Eli Lilly will buy Boston biotech Scorpion Therapeutics’ PI3Kα ... including one involving another oncology biotech—that of the Johnson and Johnson acquiring Intracellular Therapies. Pharma and ...

The Decatur County Community Foundation has received a $5 million grant to create a Crisis Intervention Team in Decatur County. Jail Commander Mike Eggleston and Decatur County Community Foundation ...

Eli Lilly will buy Boston biotech Scorpion Therapeutics ... including one involving another oncology biotech—that of the Johnson and Johnson acquiring Intracellular Therapies.